Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


49th week of 2016 patent applcation highlights part 8
Patent application numberTitlePublished
20160354356ORALLY DISINTEGRATING COMPOSITIONS2016-12-08
20160354357METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS2016-12-08
20160354358COMPOSITIONS AND METHODS FOR DRUG SENSITIZATION OF PARASITES2016-12-08
20160354359COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR2016-12-08
20160354360NICOTINE LOZENGE2016-12-08
20160354361NOVEL USE OF ARYL-QUINOLIN DERIVATIVES AS INHIBITORS OF VASCULOGENIC MIMICRY2016-12-08
20160354362COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS2016-12-08
20160354363LIQUID NALOXONE SPRAY2016-12-08
20160354364Pharmaceutical Compositions2016-12-08
20160354365Treating Pain In Patients With Hepatic Impairment2016-12-08
20160354366NOVEL USE OF TRIMETAZIDINE AS A HEPATOPROTECTIVE MEDICINE IN PREVENTION AND TREATMENT OF LIVER DISEASES AND CONDITIONS2016-12-08
20160354367Stem Cell Modulation II2016-12-08
20160354368TOPICAL FORMULATIONS FOR DELIVERY OF HEDGEHOG INHIBITOR COMPOUNDS AND USE THEREOF2016-12-08
20160354369FORMULATIONS FOR ARIPIPRAZOLE DELIVERY TRANSDERMALLY2016-12-08
20160354370METHOD FOR TREATING A PROTOZOAL INFECTION2016-12-08
20160354371LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF2016-12-08
20160354372COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS2016-12-08
20160354373METHODS OF TREATING ACUTE T CELL LEUKEMIA2016-12-08
20160354374SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH2016-12-08
20160354375CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES2016-12-08
20160354376Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient2016-12-08
20160354377SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDINES AND USES THEREOF2016-12-08
20160354378Composition for Preventing and Treating Acetaminophen Inducing Hepatotoxicity Containing TNP(N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) as an Effective Ingredient2016-12-08
20160354379COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES2016-12-08
20160354380TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN2016-12-08
20160354381DNA-PK INHIBITORS2016-12-08
20160354382GAMMA-SECRETASE INHIBITION REDUCE APOC3 LEVELS AND PLASMA TRIGLYCERIDES2016-12-08
20160354383PROSTAGLANDIN AND VASOCONSTRICTOR PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE2016-12-08
20160354384ENHANCED BIMATOPROST OPHTHALMIC SOLUTION2016-12-08
20160354385METHOD TO ENHANCE TISSUE REGENERATION2016-12-08
20160354386COMPOSITIONS AND METHODS FOR REDUCING BODY FAT2016-12-08
20160354387PHARMACEUTICAL COMPOSITION BASED ON A HEPATOPROTECTOR AND A PREBIOTIC, AND PRODUCTION AND APPLICATION THEREOF2016-12-08
20160354388Respirable Agglomerates of Porous Carrier Particles and Micronized Drug2016-12-08
20160354389NOVEL CRYSTALS AND PROCESS OF MAKING 5-(-METHYL)-2-METHOXY-BENZOIC ACID2016-12-08
20160354390PARENTAL COMPOSITIONS OF CELECOXIB2016-12-08
20160354391USE IN SINGLE PILL/TABLET/CAPSULE OF MINOCYCLINE, FLUCONAZOLE AND ATORVASTATIN IN THE TREATMENT OF MULTIPLE SCLEROSIS2016-12-08
20160354392MITOCHONDRIA-TARGETED ANTIOXIDANTS FOR TREATMENT OF AGE-RELATED BRAIN DISORDERS2016-12-08
20160354393PHARMACEUTICAL COMPOSITION INCLUDING MIGRATORY FACTOR FOR GUIDING PLURIPOTENT STEM CELLS TO DAMAGE2016-12-08
20160354394Compositions and Methods for Inhibiting Inflammation and Diseases Using an Alginic Acid-Based Antimicrobial Compound2016-12-08
20160354395INFANT FORMULAS CONTAINING A 2-FUCOSYLATED OLIGOSACCHARIDE FOR TREATMENT OR PREVENTION OF INFLUENZA INFECTION2016-12-08
20160354396THERAPEUTIC COMPOSITION2016-12-08
20160354397METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS2016-12-08
20160354398ADJUVANT CONTAINING BAICALIN, PARTICULARLY FROM A SCUTELLARIA BAICALENSIS EXTRACT, AND ANIMAL FEED CONTAINING SUCH AN ADJUVANT2016-12-08
20160354399SUBSTITUTED GEMCITABINE ARYL AMIDE ANALOGS2016-12-08
20160354400NUCLEOSIDE PHOSPHORAMIDATES2016-12-08
20160354401URIDINE DIPHOSPHATE COMPOUNDS AS MOBILIZERS OF HEMATOPOIETIC PROGENITOR CELLS2016-12-08
20160354402COMPOSITIONS2016-12-08
20160354403ENDOTHELIAL CELL GENES AND USES THEREOF2016-12-08
20160354404Compositions and Methods for Inhibition of PCSK9 Genes2016-12-08
20160354405METHOD TO PREPARE GANODERMA LUCIDUM POLYSACCHARIDES POSSESSING INSULIN-SENSITIZING PROPERTIES AND APPLICATIONS THEREOF2016-12-08
20160354406BIODEGRADABLE CONTROL OF BACTERIAL CELLULOSE BY RADIATION TECHNOLOGY AND ABSORBABLE PERIODONTAL MATERIAL USING SAME2016-12-08
20160354407Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light2016-12-08
20160354408MICRO-ORGANOIDS, AND METHODS OF MAKING AND USING THE SAME2016-12-08
20160354409NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN, NY ESO-12016-12-08
20160354410USE OF ANTI THIRD PARTY CENTRAL MEMORY T CELLS FOR ANTI-LEUKEMIA/LYMPHOMA TREATMENT2016-12-08
20160354411OLIVAMINE-INDUCED IMPROVEMENT IN ENDOTHELIAL CELLS VIABILITY AND FUNCTION2016-12-08
20160354412USE OF CELLS DERIVED FROM FIRST TRIMESTER UMBILICAL CORD TISSUE2016-12-08
20160354413ENCAPSULATED CELLS FOR TREATING LOW TESTOSTERONE IN MALE SUBJECTS2016-12-08
20160354414MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE2016-12-08
20160354415USE OF UVE BACTERIA FOR GROWTH PROMOTION IN ANIMALS2016-12-08
20160354416TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA2016-12-08
20160354417SYSTEMS, METHODS, AND COMPOSITIONS RELATING TO COMBIOMICS2016-12-08
20160354418USE OF COMPOSITIONS COMPRISING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG P-281492016-12-08
20160354419PROBIOTICS FOR USE IN RELIEVING SYMPTOMS ASSOCIATED WITH GASTROINTESTINAL DISORDERS2016-12-08
20160354420Oncolytic Adenoviruses for Cancer Treatment2016-12-08
20160354421SHELF-STABLE OLIVE EXTRACT-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF2016-12-08
20160354422FOCUS ENHANCING COMPOSITION2016-12-08
20160354423COLON VITAMIN2016-12-08
20160354424COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE2016-12-08
20160354425METHODS FOR TREATING HCV2016-12-08
20160354426METHODS OF DIAGNOSING AND TREATING ASTHMA2016-12-08
20160354427METHODS FOR INDUCING EPITHELIAL CANCER CELL SENESCENCE2016-12-08
20160354428METHODS AND COMPOSITIONS RELATED TO INHIBITION OF VIRAL ENTRY2016-12-08
20160354429Use of Melanocortins to Treat Insulin Sensitivity2016-12-08
20160354430HEXADEPSIPEPTIDE ANALOGUES AS ANTICANCER COMPOUNDS2016-12-08
20160354431COMPOSITIONS FOR PRESERVING INSULIN-PRODUCING CELLS AND INSULIN PRODUCTION AND TREATING DIABETES2016-12-08
20160354432Genetically Modified Microorganisms2016-12-08
20160354433Genetically modified microorganisms2016-12-08
20160354434Methods of Treating Medical Conditions Using Peptides2016-12-08
20160354435NORRIN REGULATION OF JUNCTION PROTEINS AND THE USE THEREOF TO TREAT EPITHELIAL OR ENDOTHELIAL MEMBRANE LEAKAGE INDUCED EDEMA2016-12-08
20160354436Compositions and Formulations for Increasing Renal Function and Treatment and Prevention of Renal Diseases, and Methods of Production and Use Thereof2016-12-08
20160354437COMPOSITIONS AND METHODS FOR MODULATION OF IMMUNE RESPONSE2016-12-08
20160354438THERAPEUTIC AND COSMETIC USES AND APPLICATIONS OF CALRETICULIN2016-12-08
20160354439BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER2016-12-08
20160354440METHODS FOR TREATING METABOLIC DISORDERS USING FGF2016-12-08
20160354441NON-SURGICAL, LOCALIZED DELIVERY OF COMPOSITIONS FOR PLACENTAL GROWTH FACTORS2016-12-08
20160354442THERAPEUTIC METHOD OF INDUCING MITOCHONDRIAL BIOGENESIS TO TREAT SKIN AND MUSCLE PATHOLOGIES2016-12-08
20160354443Replacement Therapy for Natriuretic Peptide Deficiencies2016-12-08
20160354445PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE2016-12-08
20160354446Formulation for Regeneration of Bone, Cartilage, Teeth, and Periodontium and Treatment of Tumors and Cysts2016-12-08
20160354447CARDIAC FIBROBLAST-DERIVED EXTRACELLULAR MATRIX AND INJECTABLE FORMULATIONS THEREOF FOR TREATMENT OF ISCHEMIC DISEASE OR INJURY2016-12-08
20160354448COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER2016-12-08
20160354449ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME2016-12-08
20160354450Method for Treating Adhesive Capsulitis2016-12-08
20160354451METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES AND PROTEIN AGGREGATION DISORDERS2016-12-08
20160354452MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE2016-12-08
20160354453COMPOSITIONS FOR GENERATING IMMUNE TOLERANCE BY TARGETING ERYTHROCYTES2016-12-08
20160354454METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE2016-12-08
20160354455CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF2016-12-08
20160354456METHODS FOR IDENTIFYING TUMOR-SPECIFIC POLYPEPTIDES2016-12-08
Website © 2025 Advameg, Inc.